Holen Sie sich die Stockscreener-App
1.00
6.41%
0.0602
Handel nachbörslich:
.98
-0.02
-2.00%
Schlusskurs vom Vortag:
$0.9398
Offen:
$0.9
24-Stunden-Volumen:
559.20K
Relative Volume:
1.53
Marktkapitalisierung:
$42.70M
Einnahmen:
$24.38M
Nettoeinkommen (Verlust:
$-53.95M
KGV:
-0.4049
EPS:
-2.47
Netto-Cashflow:
$-23.31M
1W Leistung:
+18.72%
1M Leistung:
+83.99%
6M Leistung:
-47.92%
1J Leistung:
-66.10%
1-Tages-Spanne:
$0.885
$1.01
1-Wochen-Bereich:
$0.8101
$1.08
52-Wochen-Spanne:
$0.50
$3.46
Elutia Inc Stock (ELUT) Company Profile
Firmenname
Elutia Inc
Sektor
Branche
Telefon
240-247-1143
Adresse
12510 PROSPERITY DRIVE, SILVER SPRING
Vergleichen Sie ELUT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ELUT
Elutia Inc
|
1.00 | 40.13M | 24.38M | -53.95M | -23.31M | -2.47 |
|
ABT
Abbott Laboratories
|
108.27 | 189.14B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
BSX
Boston Scientific Corp
|
93.61 | 138.74B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
354.57 | 136.52B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
100.69 | 129.06B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
83.60 | 48.90B | 5.88B | 1.34B | 799.60M | 2.3489 |
Elutia Inc Stock (ELUT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2020-11-02 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2020-11-02 | Eingeleitet | Cowen | Outperform |
| 2020-11-02 | Eingeleitet | Piper Sandler | Overweight |
| 2020-11-02 | Eingeleitet | Truist | Buy |
Elutia Inc Aktie (ELUT) Neueste Nachrichten
Trend Review: Can Elutia Inc be recession proofJuly 2025 Review & Breakout Confirmation Trade Signals - baoquankhu1.vn
Aug Movers: Can OPCH scale operations efficientlyMarket Performance Report & Daily Technical Stock Forecast Reports - baoquankhu1.vn
Elutia sees Q4 net sales of $3.3M - MSN
Plus Therapeutics Spurs After-Hours Biotech Rally; Connect Biopharma And Elutia Also Advance - Nasdaq
Elutia reports 16% revenue growth, advances breast reconstruction product By Investing.com - Investing.com Nigeria
Elutia reports 16% revenue growth, advances breast reconstruction product - Investing.com
Elutia (ELUT) Strengthens Position with Drug-Eluting Platform - GuruFocus
Elutia reports preliminary fourth quarter 2025 results, strengthened financial position, and upcoming Nxt-41X milestones - marketscreener.com
Elutia Reports Preliminary Fourth Quarter 2025 Results, Strengthened Financial Position, And Upcoming Nxt-41X Milestones - TradingView — Track All Markets
Elutia Reports Preliminary Fourth Quarter 2025 Results, Strengthened Financial Position, and Upcoming NXT-41x Milestones - The Manila Times
Press Release: Elutia Reports Preliminary Fourth Quarter 2025 Results, Strengthened Financial Position, and Upcoming NXT-41x Milestones - 富途资讯
Elutia, Inc.Class A Common Stock (NQ: ELUT - FinancialContent
Elutia (NASDAQ:ELUT) Shares Up 4.7% – Should You Buy? - Defense World
Elutia to Present at Global BioInnovation Forum on NXT-41x Biomatrix Program for Plastic and Reconstructive Surgery - manilatimes.net
Elutia Inc. to Highlight NXT-41x Program at Inaugural Global BioInnovation Forum during JP Morgan Healthcare Conference - Quiver Quantitative
Breast reconstruction infections hit 25% of patients. A new approach emerges - Stock Titan
Why Elutia Inc. stock attracts high net worth investorsWeekly Profit Recap & Safe Entry Zone Tips - ulpravda.ru
Why Elutia Inc. stock could rally in 2025Weekly Volume Report & Weekly Momentum Stock Picks - Улправда
How Elutia Inc. stock reacts to job market dataMarket Volume Summary & Daily Risk Controlled Trade Plans - Улправда
Will Elutia Inc. stock gain from strong economy2025 Price Momentum & Daily Chart Pattern Signal Reports - ulpravda.ru
About Us | Oil & Gas JournalElutia, Inc.Class A Common Stock (Nasdaq:ELUT) Stock Quote - FinancialContent
Elutia Inc (ELUT) upgraded to buy: Here's what you should know - MSN
Gaithersburg biotech Elutia battles to keep Nasdaq listing after asset sale - The Business Journals
Where Analysts See Viviana Power Tech Limited Stock by YearEndTechnical Analysis Insights & Small Investment Growth Plans - earlytimes.in
Elutia Faces Nasdaq Noncompliance, Considers Options to Regain Listing - The Globe and Mail
Earnings Risk: Why Elutia Inc stock attracts high net worth investorsBond Market & Breakout Confirmation Alerts - moha.gov.vn
Elutia receives Nasdaq notice for non-compliance with market value and bid price rules - Investing.com India
Elutia Received Notice of Noncompliance - TradingView — Track All Markets
Elutia faces Nasdaq noncompliance, considers options to regain listing - MSN
ELUTIA INC (ELUT) Upgraded to Buy: Here's What You Should Know - Yahoo Finance
Is Elutia Stock Built to Withstand More Downside? - Trefis
Aug Volume: What insider trading reveals about Elutia Inc. stockQuarterly Earnings Report & Long-Term Safe Return Strategies - moha.gov.vn
Why Elutia Inc. stock remains a top recommendationWeekly Profit Recap & Consistent Return Strategy Ideas - Улправда
Is Elutia Inc. stock gaining market shareEarnings Risk Report & Expert Verified Stock Movement Alerts - Улправда
Published on: 2025-12-20 12:45:53 - Улправда
What insider trading reveals about Elutia Inc. stockBreakout Watch & Fast Gain Swing Alerts - Улправда
ELUT FinancialsIncome Statement - Quiver Quantitative
Is Elutia Inc. stock near bottom after decline2025 Performance Recap & High Return Trade Opportunity Guides - Улправда
Will Elutia Inc. stock deliver consistent dividendsM&A Rumor & Risk Controlled Daily Plans - ulpravda.ru
How risky is Elutia Inc. stock nowWeekly Profit Analysis & Consistent Profit Trade Alerts - Улправда
[Form 4/A] ELUTIA INC. Amended Insider Trading Activity - Stock Titan
Insiders Make Bold Move on Elutia Stock With Fresh Buying Spree - TipRanks
[Form 4] ELUTIA INC. Insider Trading Activity - Stock Titan
Elutia (NASDAQ: ELUT) director reports purchase of 12,500 Class A shares - Stock Titan
Published on: 2025-12-19 04:35:35 - Улправда
ELUTIA Executives Increase Their Holdings - TradingView — Track All Markets
CFO Ferguson Buys 60,000 ($31.8K) Of Elutia Inc [ELUT] - TradingView — Track All Markets
Finanzdaten der Elutia Inc-Aktie (ELUT)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.36%
0.96%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):